Sanofi buoyed by generic block
502201
PARIS/LONDON  - Sanofi-Aventis SASY.PA shares   rose on Friday after a U.S. judge blocked further sales of   generic Plavix, but gains were capped as it warned cheap   supplies of the blood-thinner already in the market would hit   2006 profits.
438884
Drugmaker Sanofi-Aventis , the  target of a lawsuit seeking class-action status filed on behalf  of shareholders, on Friday vowed to fight allegations it hid  the side-effects of its anti-obesity drug Acomplia.
167015
PARIS/LONDON  - Sanofi-Aventis shares rose on   Friday after a U.S. judge blocked further sales of generic   Plavix, but gains were capped as it warned cheap supplies of   the blood-thinner already in the market would hit 2006 profits.
354450
A U.S. judge on Thursday granted a   request from Sanofi-Aventis SASY.PA and Bristol-Myers Squibb   Co. BMY.N to block the sale of a generic form of their   top-selling Plavix blood thinner.
158083
The FDA is investigating Teva's generic version of Wellbutrin XL.
97646
The Motley Fool - As investors waited anxiously for Amgen's (Nasdaq: AMGN - News) earnings report, the United Kingdom's high court snuck in with a stinker. It ruled that Transkaryotic Therapies (Nasdaq: TKTX - News) and Sanofi-Aventis (NYSE: SNYT - News) did not infringe on the patent for EPO, Amgen's anemia treatment (which accounts for 27% of its sales), and ruled the patent invalid.
469532
Judge is expected to decline motion to block a generic version of Pfizer&#39;s $3B epilepsy drug. CHICAGO  - Pfizer Inc. shares tumbled Thursday as investors worried a federal judge will refuse the company&#39;s
168451
Shares of Kos Pharmaceuticals Inc. sank 13 percent in heavy trading Thursday after an investment bank suggested that the company&#39;s key cholesterol drug may face generic competition as soon as April.
79138
Sanofi-Aventis has withdrawn its   marketing application for its Multaq heart arrhythmia treatment   in the European Union, the world's third-largest drugmaker said   on Thursday.
745053
The strategy of fighting AIDS in Africa with questionable generic drugs made in developing countries now lies in shambles as an Indian company withdrew its medicines last week because it can&#39;t guarantee they are potent enough.
365874
Sanofi&#39;s Acomplia lowers cholesterol, trims waistlines, and blocks brain receptors associated with overeating. On the market by 2006?
585414
Shares of Biovail Corp. fell Wednesday after the drug maker confirmed that a competitor had applied to the Food and Drug Administration to market a generic version of its extended-release antidepressant Wellbutrin XL.
741856
Canadian drugmaker Apotex Corp. on  Tuesday launched a generic version of Bristol-Myers Squibb  Co.'s  blockbuster Plavix anti-clotting medicine,  threatening Bristol's earnings outlook and dividend.
768602
Shares of Sanofi-Aventis SA, the world&#39;s third biggest drugmaker, may rise after research presented at Europe&#39;s largest medical meeting showed two of the company&#39;s new drugs may benefit heart patients.
459566
LONDON/NEW YORK  - A court ruling upholding the patent on blockbuster blood-thinning drug Plavix has reignited talk France's Sanofi-Aventis  will bid for its smaller U.S. partner Bristol-Myers Squibb Co. .
678626
A cheap generic version of blood thinner Plavix, which is used by 48 million Americans, has been blocked by a judge because of a patent dispute just three weeks after it launched.
141602
Ranbaxy, one of India's leading drug companies, is seeking US drug authority approval for two of it s generic Aids treatments